Ipca Laboratories (India) Financial Diagnostics

IPCALAB -- India Stock  

INR 732.75  11.95  1.66%

The recent decline in stock price may raise some interest from investors. The Stock closed today at a share price of 730.25 on 19032.000 in trading volume. The company executives have failed to build on market volatilities in January. However, diversifying your overall positions with Ipca Laboratories may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.8009. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. This diagnostics interface makes it easy to digest most current publicly released information about Ipca Laboratories as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Ipca Laboratories price relationship with some important fundamental indicators such as market cap and management efficiency. Please also check Risk vs Return Analysis.

Ipca Laboratories Note

The book value of the company was currently reported as 213.04. The company has Price/Earnings To Growth (PEG) ratio of 1.03. Ipca Laboratories recorded earning per share (EPS) of 18.97. The entity last dividend was issued on 2018-08-02. The firm had 5:1 split on 2010-03-22. Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients for various therapeutic segments in India. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India. Ipca Laboratories operates under Drug Manufacturers - Specialty Generic classification in India and is traded on National Stock Exchange of India. It employs 5051 people. To learn more about IPCA LABORATORIES call the company at 91 22 6647 4747 or check out http://www.ipca.com.

Ipca Laboratories Alerts

Ipca Laboratories is not yet fully synchronised with the market data
Ipca Laboratories generates negative expected return over the last 30 days

Ipca Laboratories Thematic Classifications

Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French

Market Capitalization

The company currently falls under 'Large-Cap' category with current market capitalization of 99.72B.


The company has Profit Margin (PM) of 7.29 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 8.48 % which suggests for every 100 dollars of sales it generated a net operating income of 0.08.

Management Efficiency

Ipca Laboratories has return on total asset (ROA) of 4.31 % which means that it generated profit of $4.31 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 9.31 % meaning that it generated $9.31 on every $100 dollars invested by stockholders.

Ipca Laboratories Technical and Predictive Indicators

Did you try this?

Run Insider Screener Now


Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Insider Screener

Also Currentnly Active

Purchased over 40 shares of
six days ago
Traded for 62.81
Purchased over 20 shares of
six days ago
Traded for 140.38
Purchased over 20 shares of
six days ago
Traded for 140.38
Please also check Risk vs Return Analysis. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Search macroaxis.com